Blueweave
Global Bioanalytical Testing Services Market

Global Bioanalytical Testing Services Market

Special Offer: SPECIAL OFFER: Avail Attractive Year End Discount!

Global Bioanalytical Testing Services Market, By Test Type (Cell-Based Assays, Virology Testing, Species-Specific Viral PCR Assays, Serology, Immunogenicity & Neutralizing Antibodies, Biomarker Testing, Pharmacokinetic Testing, Other Services); By Molecule Size (Smaller Molecule and Larger Molecule); By Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, Other Applications); By End-Users (Pharmaceutical and Biopharmaceutical Companies Therapeutic, Contract Development and Manufacturing Organizations, Contract Research Organizations); By Region (North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: March 2021
  • Report ID: BWC20302
  • Available Format: PDF
  • Page: 179

Report Overview

Global bioanalytical testing services market was worth USD 2.7 billion in 2020 and is further projected to reach USD 6.1 billion by 2027, at a CAGR of 12.1% during the forecast period (2021-2027).

Global Bioanalytical Testing Services Market- Industry Trends & Forecast Report 2027

Global bioanalytical testing services market was worth USD 2.7 billion in 2020 and is further projected to reach USD 6.1 billion by 2027, at a CAGR of 12.1% during the forecast period (2021-2027). The growing demand for analytical testing for biologics and biosimilars, small-molecule and large-molecule drugs, and the preference for analytical outsourcing are all contributing to the market's growth. Furthermore, pharmaceutical and biopharmaceutical companies have been increasingly investing in research and development, which in turn is boosting the overall market growth. At the same time, rising government practices to control pandemics like COVID-19, Ebola virus, and others are also fueling the growth of the market. According to a report released by the World Health organization, there are 11,77,99,584 confirmed cases of COVID-19 worldwide with 2615018 deaths. 

Source: BlueWeave Consulting

Global Bioanalytical Testing Services Overview

Bioanalytical testing is used for determining the properties of drugs and metabolites in biological matrices like blood, tissue, urine, plasma, etc.  Bioanalytical methods and assay validation allow accurate quantitation of analytes and biomarkers in various biological matrices to assess drug safety and efficacy. This diagnostic technique has several applications, including drug testing and assessment, oncology, neurology, cardiology, and others. Bioanalytical testing services assist in the evaluation of a drug's design effects, drawbacks, suitable circumstances, and suitability for the intended treatment. Before starting as say creation and validation, it's a good idea to learn about the analyte's physicochemical properties.

Global Bioanalytical Testing services market Trend

Growth Drivers

Increased Number of laboratory Outsourcing Service

The trend of outsourcing bioanalytical services is growing by leaps and bounds for better resource utilization.While dedicated in-house laboratories have advanced facilities, they may not be able to handle complex bioanalytical testing. Moreover, on a strategic level, operating in-house laboratories can be a costly affair. On the other hand, outsourcing the lab role decreases overhead and operational costs owing to which business companies continue to benefit from such lab services. Lab outsourcing helps companies and other institutions to make a profit as it allows to trade higher fixed-costs for lower variable-costs, thereby reducing the need for capital investment in the company and allowing instant access to world-class analytical expertise and capabilities on a short notice period. The aforementioned factors are significantly driving the market growth.

Rise in the R&D Expenditure in the Pharmaceutical and Biopharmaceutical Industry

The pharmaceutical industry spent a total of 136 billion dollars in 2012. In 2019, it spent 186 billion dollars on research and development. According to PhRMA, research and development (R&D) investment by PhRMA member companies totaled 83 billion US dollars in 2019, making the biopharmaceutical industry the most R&D-intensive industry in the US economy. In fact, the biopharmaceutical industry spends six times as much in research and development as all other manufacturing sectors combined.PhRMA member companies have invested nearly USD 1 trillion in the quest for and creation of new and improved drugs and cures over the last few decades.

The regulatory authority is involved in the process at some point, usually during the pre-clinical phase, to oversee, control, and eventually authorize the drug. In recent years, major developments in pharmaceutical research and development have begun to alter the R&D landscape. To cut costs, a growing number of drug manufacturers are outsourcing large parts of R&D, mostly to clinical research organizations, also known as contract research organizations.

Restrains

The Lack of Dearth of Skilled Professionals

The rising demand for skilled health care practitioners is not exclusive to The United States. According to a report published in the journal Human Resources for Health in 2016, 80 million health care staff will be needed globally by 2030. Nevertheless, only 65 million healthcare workers are projected to be available by 2020, leaving a global shortage of 15 million. Even though the basic threshold for health care staff is 23 qualified professionals per 10,000 populations, 83 countries still fall short of the target. 6.6 million children under the age of five died in the year 2012. The majority of deaths were caused by diseases that could have been avoided or treated. Moreover, 80% of stillbirths and 90% of maternal deaths occur in almost 58 countries. Increasing access to quality healthcare in specific areas of the world may have a huge effect on these findings.

Impact of COVID-19

The COVID-19 pandemic has severely affected the global economy besides affecting business operations. Due to the high infection rates and adverse impact on public health systems, various countries had to enforce nationwide lockdowns which had a major impact on industrial supply chains, trade, and related services.

Global bioanalytical testing services also saw a downfall in the market due to COVID-19. Moreover, limited access to clinics, combined with social distancing norms and complete lockdown declared by several countries resulted in a slow-down in patient flow and referral, which in turn has impacted the market growth. During the COVID-19 epidemic, cancer screenings fell sharply. Repeated screenings for cervical cancer went down by 68% across the USA in the first 15 weeks of 2020, while breast cancer checking went down by 17%, with more significant declines in areas where the outbreak was the sturdiest.

Global Bioanalytical Testing services market: By End-User

Based on end-user, the global bioanalytical testing services market is grouped into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations. In 2020, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the bioanalytical testing services market. Pharmaceutical companies nowadays are increasingly outsourcing early-stage development, clinical, and laboratory testing services to increase profit margins, avoid high capital expenditure, and reduce the time it takes to validate processes and services, which accounts for a significant share of this segment.

 

Source: BlueWeave Consulting

 

Global Bioanalytical Testing Services Market: By Molecule

Based on molecule size, the global bioanalytical testing services market is fragmented into small molecules and large molecules. Since they play such an important role in the production of generic versions of branded drugs, the small molecule testing services sub-segment is expected to have the largest revenue share in the bioanalytical testing services industry.These bioanalytical testing results plays a significant role in demonstrating the efficacy of simulating generic drug release profiles, resulting in the segment's development.

Global Bioanalytical Testing services market: Regional Insights

Geographically, the global bioanalytical testing services market is categorized into North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America. North America leads the global bioanalytical testing services industry and is projected to lead the overall industry during the forecast period. The growth is mainly driven by the presence of major industry players in the region, the increasing number of pharmaceutical and biopharmaceutical companies, technological developments, and government initiatives that have increased North America's demand for bioanalytical testing services. 

 

Competitive Landscape

The bioanalytical testing services market's high growth potential has drawn a slew of new entrants, creating a lucrative opportunity. The emergence of new entrants has resulted in more healthy competition among long-established service providers. In the present scenario, many contract development and manufacturing organizations (CDMOs), which have analytical capabilities to support their manufacturing activities and development, are offering analytical services and some guided expertise to other laboratories as well.

Some of the key players include Charles River laboratories, Medpace, Wuxi Apptec, Eurofins Scientific, Iqvia Inc., Sgs Sa, Laboratory Corporation of America Holdings, Intertek Group Plc, Pra Health Sciences, Syneos Health, Icon Plc, Frontage Labs, and other prominent players. In order to improve their production capability, product portfolio, and provide competitively differentiation, companies are increasingly participating in acquisitions, alliances, and mergers.

Recent Development

·         On 17 February 2021, Charles River Laboratories announced the acquisition of Cognate BioServices, a premier cell and gene therapy contract development and manufacturing organization (CDMO), and Cobra Biologics, its gene therapy division. The planned acquisition will establish Charles River as a leading scientific partner for cell and gene therapy development, testing, and manufacturing, providing clients with an integrated solution from early research and discovery through CGMP production.

·         On 10 February 2020, SGS SA announced that its Center of Excellence for Biosafety laboratory will offer Good Manufacturing Practice (GMP)-compliant vaccine testing solutions for coronavirus which is likely to help in the detection of novel coronavirus with effective testing solutions.

 

Scope of the Report

Attribute

Details

Years Considered

Historical data – 2017-2020

Base Year – 2020

Forecast – 2021 – 2027

Facts Covered

Revenue in USD Billion

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia

Product/Service Segmentation

By test type, application, molecule size, end-users, and region

Key Players

Key Players for the market are Charles River, Medpace, Wuxi Apptec, Eurofins Scientific, Iqvia Inc., Sgs Sa, Laboratory Corporation of America Holdings, Intertek Group Plc, Pra Health Sciences, Syneos Health, Icon Plc, Frontage Labs, Other Prominent Players

 

 

By Test Type

  • Cell-Based Assays
  • Virology Testing
  • Species-Specific Viral PCR Assays
  • Serology, Immunogenicity & Neutralizing Antibodies
  • Biomarker Testing
  • Pharmacokinetic Testing
  • Other Services

By Molecule Size

  • Smaller Molecule
  • Larger Molecule

By Application

  • Oncology
  • Neurology
  • Infectious Diseases
  • Gastroenterology
  • Cardiology
  • Other Applications

By End-Users

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Development and Manufacturing Organizations
  • Contract Research Organizations

By Region

  • The Asia-Pacific
  • North America
  • Europe
  • The Middle East & Africa
  • Latin America

 

FAQs:

 

  1. What is the current size of the global bioanalytical testing services market?

Answer: The global bioanalytical testing services market has reached USD 2.7 billion in 2020.

  1. What are the major factors driving the growth of the global bioanalytical testing services market?

Answer: The major factors driving the growth of the global bioanalytical testing services the market is the increased number of laboratory outsourcing services and increasing R&Dinvestments in the pharmaceutical and biopharmaceutical industry.

  1. Who are the key players in the global bioanalytical testing services market?

Answer: The key players in the global bioanalytical testing services market are Charles River Laboratories, Medpace, Wuxi Apptec, Eurofins Scientific, Iqvia Inc., Sgs Sa, Laboratory Corporation of America Holdings, Intertek Group Plc, Pra Health Sciences, Syneos Health, Icon Plc, Frontage Labs, Other Prominent Players, and other prominent players.

  1. Which end-user accounted for the largest share in the global bioanalytical testing services market?

Answer: Pharmaceutical and Biopharmaceutical Companies by end-user accounted for the largest share in the global bioanalytical testing services market.

  1. Which region is growing at a higher rate in the global bioanalytical testing services market?

Answer: North America is growing at a higher rate in the global bioanalytical testing services market.

-

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Research

2.2. Quantitative Research

2.3. Market Breakdown & Data Triangulation

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Region

2.5. Assumption & Limitation

3.    Executive Summary

4.    Global Bioanalytical Testing Services MarketInsights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Recent Development

4.4. Government Regulations

4.5. Porter’s Five Forces Analysis

4.5.1.   Bargaining Power of Suppliers

4.5.2.   Bargaining Power of Buyers

4.5.3.   Threat of New Entrants

4.5.4.   Threat of Substitutes

4.5.5.   Intensity of Rivalry

5.    Global Bioanalytical Testing Services MarketOverview

5.1. Market Size & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Billion)

5.2. Market Share & Forecast

5.2.1.   By Test Type

5.2.1.1.       Cell-Based Assays

5.2.1.1.1.           Bacterial Cell-Based Assays

5.2.1.1.2.           Viral Cell-Based Assays

5.2.1.2.       Virology Testing

5.2.1.2.1.           In Vitro Virology Testing

5.2.1.2.2.           In Vivo Virology Testing

5.2.1.3.       Species-Specific Viral Pcr Assays

5.2.1.4.       Serology, Immunogenicity, And Neutralizing Antibodies

5.2.1.5.       Biomarker Testing

5.2.1.6.       Pharmacokinetic Testing

5.2.1.7.       Other Services

5.2.2.   By Molecule Size

5.2.2.1.       Small Molecule

5.2.2.2.       Large Molecule

5.2.3.   By Application

5.2.3.1.       Oncology

5.2.3.2.       Neurology

5.2.3.3.       Infectious Diseases

5.2.3.4.       Gastroenterology

5.2.3.5.       Cardiology

5.2.3.6.       Other Applications

5.2.4.   By End-Users

5.2.4.1.       Pharmaceutical and Biopharmaceutical Companies Therapeutic

5.2.4.2.       Contract Development and Manufacturing Organizations

5.2.4.3.       Contract Research Organizations

5.2.5.   By Region

5.2.5.1.     North America

5.2.5.2.     Europe

5.2.5.3.     The Asia-Pacific

5.2.5.4.     Latin America

5.2.5.5.     The Middle East and Africa

6.    North America Bioanalytical Testing Services Market

6.1. Market Size & Forecast by Value, 2017-2027

6.1.1.   By Value (USD Billion)

6.2. Market Share & Forecast

6.2.1.   By Test Type

6.2.2.   By Molecule Size

6.2.3.   By Application

6.2.4.   By End-Users

6.2.5.   By Country

6.2.5.1.     United States

6.2.5.2.     Canada

7.    Europe Bioanalytical Testing Services Market

7.1. Market Size & Forecast by Value, 2017-2027

7.1.1.   By Value (USD Billion)

7.2. Market Share & Forecast

7.2.1.   By Test Type

7.2.2.   By Molecule Size

7.2.3.   By Application

7.2.4.   By End-Users

7.2.5.   By Country

7.2.5.1.     Germany

7.2.5.2.     United Kingdom

7.2.5.3.     Italy

7.2.5.4.     France

7.2.5.5.     Spain

7.2.5.6.     Rest of Europe

8.    Asia Pacific Bioanalytical Testing Services Market

8.1. Market Size & Forecast by Value, 2017-2027

8.1.1.   By Value (USD Billion)

8.2. Market Share & Forecast

8.2.1.   By Test Type

8.2.2.   By Molecule Size

8.2.3.   By Application

8.2.4.   By End-Users

8.2.5.   By Country

8.2.5.1.     China

8.2.5.2.     India

8.2.5.3.     Japan

8.2.5.4.     Australia

8.2.5.5.     South Korea

8.2.5.6.     Rest of Asia Pacific

9.    Latin America Bioanalytical Testing Services Market

9.1.   Market Size & Forecast by Value, 2017-2027

9.1.1.       By Value (USD Billion)

9.2. Market Share & Forecast

9.2.1.       By Test Type

9.2.2.      By Molecule Size

9.2.3.       By Application

9.2.4.       By End-Users

9.2.5.       By Country

9.2.5.1.     Brazil

9.2.5.2.     Mexico

9.2.5.3.     Argentina

9.2.5.4.     Rest of Latin America

10. The Middle East & AfricaBioanalytical Testing Services Market

10.1. Market Size & Forecast by Value, 2017-2027

10.1.1.   By Value (USD Billion)

10.2. Market Share & Forecast

10.2.1.     By Test Type

10.2.2.     By Molecule Size

10.2.3.     By Application

10.2.4.     By End-Users

10.2.5.     By Country

10.2.5.1.  Saudi Arabia

10.2.5.2.  Turkey

10.2.5.3.  UAE

10.2.5.4.  South Africa

10.2.5.5.  Rest of The Middle East & Africa

11. Competitive Landscape

11.1.          List of Key Players and Their Offerings

11.2.          Market Share Analysis, 2020

11.3.          Competitive Benchmarking, By Operating Parameters

12. Impact of Covid-19 on Bioanalytical Testing Services Market Industry

13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **

13.1.  Charles River Laboratories

13.2.  Medpace

13.3.  Wuxi Apptec

13.4.  Eurofins Scientific

13.5.  Iqvia Inc.

13.6.  SGS SA

13.7.  Laboratory Corporation of America Holdings

13.8.  Intertek Group Plc

13.9.  Pra Health Sciences

13.10.   Syneos Health

13.11.   Icon Plc

13.12.   Frontage Labs

13.13.   Other Prominent Player

Key Strategic Recommendations

 

List of Figures

 

Fig: Global Bioanalytical Testing ServicesSegmentation

Fig: Global Bioanalytical Testing Services Market Value Chain Analysis

Fig: Company Market Share Analysis, 2020

Fig: Global Bioanalytical Testing Services Market Size, By Value (USD Billion), 2017-2027

Fig: Global Bioanalytical Testing Services Market Share, By Test Type, By Value, 2017-2027

Fig: Global Bioanalytical Testing Services Market Share, By Molecule Size, By Value, 2017-2027

Fig: Global Bioanalytical Testing Services Market Share, By Application, By Value, 2017-2027

Fig: Global Bioanalytical Testing Services Market Share, By End-Users, By Value, 2017-2027

Fig: Global Bioanalytical Testing Services Market Share, By Region, By Value, 2017-2027

Fig: North America Bioanalytical Testing Services Market Size, By Value (USD Billion), 2017-2027

Fig: North America Bioanalytical Testing Services Market Share, By Test Type, By Value, 2017-2027

Fig: North America Bioanalytical Testing Services Market Share, By Molecule Size, By Value, 2017-2027

Fig: North America Bioanalytical Testing Services Market Share, By Application, By Value, 2017-2027

Fig: North America Bioanalytical Testing Services Market Share, By Country, By Value, 2017-2027

Fig: Europe Bioanalytical Testing Services Market Size, By Value (USD Billion), 2017-2027

Fig: Europe Bioanalytical Testing Services Market Share, By Test Type, By Value, 2017-2027

Fig: Europe Bioanalytical Testing Services Market Share, By Molecule Size, By Value, 2017-2027

Fig: Europe Bioanalytical Testing Services Market Share, By Application, By Value, 2017-2027

Fig: Europe Bioanalytical Testing Services Market Share, By End-Users, By Value, 2017-2027

Fig: Europe Bioanalytical Testing Services Market Share, By Country, By Value, 2017-2027

Fig: The Asia-PacificBioanalytical Testing Services Market Size, By Value (USD Billion), 2017-2027

Fig: The Asia-PacificBioanalytical Testing Services Market Share, By Test Type, By Value, 2017-2027

Fig: The Asia-Pacific Bioanalytical Testing Services Market Share, By Molecule Size, By Value, 2017-2027

Fig: The Asia-PacificBioanalytical Testing Services Market Share, By Application, By Value, 2017-2027

Fig: The Asia-PacificBioanalytical Testing Services Market Share, By End-Users, By Value, 2017-2027

Fig: The Asia-PacificBioanalytical Testing Services Market Share, By Country, By Value, 2017-2027

Fig: Latin America Bioanalytical Testing Services Market Size, By Value (USD Billion), 2017-2027

Fig: Latin America Bioanalytical Testing Services Market Share, By Test Type, By Value, 2017-2027

Fig: Latin America Bioanalytical Testing Services Market Share, By Molecule Size, By Value, 2017-2027

Fig: Latin America Bioanalytical Testing Services Market Share, By Application, By Value, 2017-2027

Fig: Latin America Bioanalytical Testing Services Market Share, By End-Users, By Value, 2017-2027

Fig: Latin America Bioanalytical Testing Services Market Share, By Country, By Value, 2017-2027

Fig: The Middle East & AfricaBioanalytical Testing Services Market Size, By Value (USD Billion), 2017-2027

Fig: The Middle East & AfricaBioanalytical Testing Services Market Share, By Test Type, By Value, 2017-2027

Fig: The Middle East & Africa Bioanalytical Testing Services Market Share, By Molecule Size, By Value, 2017-2027

Fig: The Middle East & AfricaBioanalytical Testing Services Market Share, By Application, By Value, 2017-2027

Fig: The Middle East & AfricaBioanalytical Testing Services Market Share, By End-Users, By Value, 2017-2027

Fig: The Middle East & AfricaBioanalytical Testing Services Market Share, By Country, By Value, 2017-2027

 

List of Table

Table: Global Bioanalytical Testing Services Market Size, By Test Type, By Value, 2017-2027

Table: Global Bioanalytical Testing Services Market Size, By Molecule Size, By Value, 2017-2027

Table: Global Bioanalytical Testing Services Market Size, By Application, By Value, 2017-2027

Table: Global Bioanalytical Testing Services Market Size, By End-Users, By Value, 2017-2027

Table: Global Bioanalytical Testing Services Market Size, By Region, By Value, 2017-2027

Table: North America Bioanalytical Testing Services Market Size, By Test Type, By Value, 2017-2027

Table: North America Bioanalytical Testing Services Market Size, By Molecule Size, By Value, 2017-2027

Table: North America Bioanalytical Testing Services Market Size, By Application, By Value, 2017-2027

Table: North America Bioanalytical Testing Services Market Size, By End-Users, By Value, 2017-2027

Table: North America Bioanalytical Testing Services Market Size, By Country, By Value, 2017-2027

Table: Europe Bioanalytical Testing Services Market Size, By Test Type, By Value, 2017-2027

Table: Europe Bioanalytical Testing Services Market Size, By Molecule Size, By Value, 2017-2027

Table: Europe Bioanalytical Testing Services Market Size, By Application, By Value, 2017-2027

Table: Europe Bioanalytical Testing Services Market Size, By End-Users, By Value, 2017-2027

Table: Europe Bioanalytical Testing Services Market Size, By Country, By Value, 2017-2027

Table: The Asia-PacificBioanalytical Testing Services Market Size, By Test Type, By Value, 2017-2027

Table: The Asia-Pacific Bioanalytical Testing Services Market Size, By Molecule, By Value, 2017-2027

Table: The Asia-PacificBioanalytical Testing Services Market Size, By Application, By Value, 2017-2027

Table: The Asia-PacificBioanalytical Testing Services Market Size, By End-Users, By Value, 2017-2027

Table: The Asia-PacificBioanalytical Testing Services Market Size, By Country, By Value, 2017-2027

Table: Latin America Bioanalytical Testing Services Market Size, By Test Type, By Value, 2017-2027

Table: Latin America Bioanalytical Testing Services Market Size, By Molecule Size, By Value, 2017-2027

Table: Latin America Bioanalytical Testing Services Market Size, By Application, By Value, 2017-2027

Table: Latin America Bioanalytical Testing Services Market Size, By End-Users, By Value, 2017-2027

Table: Latin America Bioanalytical Testing Services Market Size, By Country, By Value, 2017-2027

Table: The Middle East & AfricaBioanalytical Testing Services Market Size, By Test Type, By Value, 2017-2027

Table: The Middle East & AfricaBioanalytical Testing Services Market Size, By Application, By Value, 2017-2027

Table: The Middle East & AfricaBioanalytical Testing Services Market Size, By End-Users, By Value, 2017-2027

Table: The Middle East & AfricaBioanalytical Testing Services Market Size, By Country, By Value, 2017-2027

Table: Charles River Laboratories Financial Analysis

Table: Charles River Laboratories Business Overview

Table: Medpace Financial Analysis

Table: Medpace Business Overview

Table: Wuxi ApptecFinancial Analysis

Table: Wuxi ApptecBusiness Overview

Table: Eurofins Scientific Financial Analysis

Table: Eurofins Scientific Business Overview

Table: Iqvia Inc. Financial Analysis

Table: Iqvia Inc. Business Overview

Table: SGS SAFinancial Analysis

Table: SGS SA Business Overview

Table: Laboratory Corporation of America Holdings Financial Analysis

Table: Laboratory Corporation of America Holdings Business Overview

Table: Intertek Group Plc Financial Analysis

Table: Intertek Group Plc Business Overview

Table: Pra Health SciencesFinancial Analysis

Table: Pra Health SciencesBusiness Overview

Table: Syneos Health Financial Analysis

Table: Syneos Health Business Overview

Table: Icon Plc Financial Analysis

Table: Icon Plc Business Overview

Table: Frontage Labs Financial Analysis

Table: Frontage Labs Business Overview

 

 

 

Market Segmentation

By Test Type

Ø Cell-Based Assays

Ø Virology Testing

Ø Species-Specific Viral PCR Assays

Ø Serology, Immunogenicity & Neutralizing Antibodies

Ø Biomarker Testing

Ø Pharmacokinetic Testing

Ø Other Services

By Molecule Size

Ø Smaller Molecule

Ø Larger Molecule

By Application

Ø Oncology

Ø Neurology

Ø Infectious Diseases

Ø Gastroenterology

Ø Cardiology

Ø Other Applications

By End-Users

Ø Pharmaceutical and Biopharmaceutical Companies

Ø Contract Development and Manufacturing Organizations

Ø Contract Research Organizations

By Region

Ø The Asia-Pacific

Ø North America

Ø Europe

Ø The Middle East & Africa

Ø Latin America

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.